financial estimates
Bruker Preliminary Q1 Revenues Rise 10 Percent Year Over Year
Bruker also announced a majority investment in and collaboration with German infectious disease bioinformatics firm Ridom.
Qiagen Preliminary Q1 Net Sales Up 5 Percent, Firm Raises 2025 EPS Estimate
The firm's guidance raise was seen by analysts as a positive indicator for companies with recurring NIH revenues.
At JP Morgan, Myriad Genetics Says Q4 Test Volumes Disappointing, Firm Preps New Launches in 2025
Premium
The firm announced preliminary full-year 2024 revenue estimates that were slightly below expectations.
Executives also provided additional information on the firm's Q4 2024 financial performance.
The firm said preliminary core Q4 2024 revenues are expected to be flat, exceeding prior expectations, while its China business has stabilized and will recover.
Jul 8, 2024
MDxHealth Preliminary Q2 Revenues up 32 Percent
May 3, 2024
Fulgent Genetics Core Q1 Revenues Grow 1 Percent
Nov 8, 2023